Načítá se...
Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist- managed anticoagulation clinic
Background : Vitamin K antagonists have been the treatment of choice in preventing thromboembolic events, but problems such as frequent dose adjustment and monitoring of coagulation status, including multiple drug and food interactions, make their use difficult. Dabigatran etexilate is a new oral di...
Uloženo v:
| Vydáno v: | Pharmacy Practice |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Centro de investigaciones y Publicaciones Farmacéuticas
2013
|
| Témata: | |
| On-line přístup: | https://www.redalyc.org/articulo.oa?id=69028370004 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|